The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues

Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters Vol. 500; no. 3; pp. 145 - 148
Main Authors: Warburton, Michael J, Bernardini, Francesca
Format: Journal Article
Language:English
Published: England Elsevier B.V 06-07-2001
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P 1 and P 1′ positions on the rate of catalysis. With the exception of angiotensin-(1–8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length. K cat/ K m values increase 50-fold between angiotensin-(1–5) and angiotensin-(1–14). TPP-I shows little specificity for the nature of the amino acids in the P 1 and P 1′ positions, K cat/ K m values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P 1 position and Pro in the P 1′ positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation.
AbstractList Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P1 and P1' positions on the rate of catalysis. With the exception of angiotensin-(1-8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length. K(cat)/K(m) values increase 50-fold between angiotensin-(1-5) and angiotensin-(1-14). TPP-I shows little specificity for the nature of the amino acids in the P1 and P1' positions, K(cat)/K(m) values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P1 position and Pro in the P1' positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation.
Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P 1 and P 1′ positions on the rate of catalysis. With the exception of angiotensin-(1–8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length. K cat/ K m values increase 50-fold between angiotensin-(1–5) and angiotensin-(1–14). TPP-I shows little specificity for the nature of the amino acids in the P 1 and P 1′ positions, K cat/ K m values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P 1 position and Pro in the P 1′ positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation.
Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP‐I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin‐II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P1 and P1′ positions on the rate of catalysis. With the exception of angiotensin‐(1–8) (angiotensin‐II), which is a relatively poor substrate for TPP‐I, the rate of catalysis increases with increasing chain length. K cat/K m values increase 50‐fold between angiotensin‐(1–5) and angiotensin‐(1–14). TPP‐I shows little specificity for the nature of the amino acids in the P1 and P1′ positions, K cat/K m values varying only 5‐fold for a range of substitutions. However, Pro or Lys in the P1 position and Pro in the P1′ positions are incompatible with TPP‐I activity. These observations suggest that TPP‐I is a non‐specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation.
Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP‐I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin‐II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P 1 and P 1 ′ positions on the rate of catalysis. With the exception of angiotensin‐(1–8) (angiotensin‐II), which is a relatively poor substrate for TPP‐I, the rate of catalysis increases with increasing chain length. K cat / K m values increase 50‐fold between angiotensin‐(1–5) and angiotensin‐(1–14). TPP‐I shows little specificity for the nature of the amino acids in the P 1 and P 1 ′ positions, K cat / K m values varying only 5‐fold for a range of substitutions. However, Pro or Lys in the P 1 position and Pro in the P 1 ′ positions are incompatible with TPP‐I activity. These observations suggest that TPP‐I is a non‐specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation.
Author Warburton, Michael J
Bernardini, Francesca
Author_xml – sequence: 1
  givenname: Michael J
  surname: Warburton
  fullname: Warburton, Michael J
  email: mwarburt@sghms.ac.uk
– sequence: 2
  givenname: Francesca
  surname: Bernardini
  fullname: Bernardini, Francesca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11445074$$D View this record in MEDLINE/PubMed
BookMark eNqNkE1v1DAQhi3Uim4LPwHkE4JDWn8nOaFStXSlSj1QzpbXHhejJA62F5R_T7JZwREkS-OZeeed0XOOToY4AEJvKLmkhKqrL4RQUcm65e8J_UCYIk0lXqANbWpecaGaE7T5IzlD5zl_J3Pe0PYlOqNUCElqsUHh6RvgPIINPthQJhw97qYcc-xNh0sKI4wluKnD68dkqLbYQYHUhwEc3k04lIyNLSEOeH5meA6xwJDDUG23c2q6-LyH_AqdetNleH2MF-jr3e3TzX318Ph5e3P9UFnBlKi8bRTzO0E4kdRxaRxvmbLMSE9Ia7hkLYjaO6FaRneKCSVBOtbwuiXQeMkv0LvVd0zxx7y36D5kC11nBoj7rGs6c5DNIpSr0KaYcwKvxxR6kyZNiV4Y6wNjvQDUhOoDYy3mubfHBftdD-7v1BHqLLhfBb9CB9P_ueq720_s0FkahB7Ki9XH1QpmYj8DJJ1tgMGCCwls0S6Gf1z7Gxj3oWc
CitedBy_id crossref_primary_10_1016_j_bbrc_2004_04_142
crossref_primary_10_1007_s10048_005_0218_3
crossref_primary_10_1007_s10741_007_9078_2
crossref_primary_10_1093_jb_mvi110
crossref_primary_10_1007_s00018_010_0468_6
crossref_primary_10_1016_j_peptides_2016_01_009
crossref_primary_10_1111_j_1750_3639_2004_tb00501_x
crossref_primary_10_1111_j_1750_3639_2004_tb00077_x
crossref_primary_10_1074_jbc_M507336200
crossref_primary_10_1679_aohc_76_1
Cites_doi 10.1074/jbc.M008562200
10.1016/S0014-5793(98)01683-4
10.1073/pnas.84.21.7508
10.1046/j.1471-4159.2000.0740287.x
10.1006/bbrc.2000.2207
10.1002/ajmg.1320420428
10.1210/endo-103-5-1794
10.1093/oxfordjournals.jbchem.a022781
10.1006/abbi.1993.1523
10.1074/jbc.270.26.15798
10.1111/j.1440-1681.1996.tb02817.x
10.1016/0006-291X(85)90571-6
10.1016/S0167-4838(98)00012-0
10.1007/978-1-4615-5833-0_6
10.1126/science.277.5333.1802
10.1016/S0021-9258(17)35951-3
ContentType Journal Article
Copyright 2001 Federation of European Biochemical Societies
FEBS Letters 500 (2001) 1873-3468 © 2015 Federation of European Biochemical Societies
Copyright_xml – notice: 2001 Federation of European Biochemical Societies
– notice: FEBS Letters 500 (2001) 1873-3468 © 2015 Federation of European Biochemical Societies
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/S0014-5793(01)02608-4
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1873-3468
EndPage 148
ExternalDocumentID 10_1016_S0014_5793_01_02608_4
11445074
FEB2S0014579301026084
S0014579301026084
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
-~X
.55
.~1
0R~
0SF
1B1
1OC
1~.
1~5
24P
29H
2WC
33P
4.4
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
8P~
AABNK
AACTN
AAEDW
AAESR
AAFTH
AAHHS
AAIKJ
AAJUZ
AALRI
AANLZ
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABBQC
ABCUV
ABEFU
ABFNM
ABFRF
ABGSF
ABHUG
ABJNI
ABLJU
ABMAC
ABQWH
ABVKL
ABXDB
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIUM
ACMXC
ACNCT
ACPOU
ACXBN
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADEZE
ADIYS
ADKYN
ADMGS
ADMUD
ADOZA
ADQTV
ADUVX
ADXAS
ADZMN
ADZOD
AEEZP
AEFWE
AEGXH
AEKER
AENEX
AEQDE
AEQOU
AEUQT
AEUYR
AEXQZ
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFVGU
AFZJQ
AGHFR
AGJLS
AGYEJ
AHBTC
AHPSJ
AI.
AIACR
AIAGR
AITUG
AIURR
AIWBW
AJBDE
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AMYDB
AZFZN
AZVAB
BAWUL
BFHJK
BMXJE
C45
CBWCG
CS3
DCZOG
DIK
DOVZS
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FUBAC
G-Q
GBLVA
GI5
GX1
HVGLF
HZ~
IHE
IXB
J1W
KBYEO
L7B
LATKE
LCYCR
LEEKS
LITHE
LOXES
LUTES
LX3
LYRES
M41
MEWTI
MO0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N9A
NCXOZ
O-L
O9-
OK1
OVD
OZT
P-8
P-9
P2P
P2W
PC.
Q38
R2-
R9-
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SFE
SSZ
SUPJJ
SV3
TEORI
TR2
UHB
UNMZH
VH1
WBKPD
WH7
WIH
WIJ
WIK
WIN
WOHZO
WXSBR
X7M
XFK
Y6R
YK3
ZA5
ZGI
ZZTAW
~02
AAHBH
ADVLN
AITYG
AKRWK
ALUQN
HGLYW
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4264-fc862fb403051d35ad3926c2a5f009a3529e47fd46921b62465e5d283790e8f53
IEDL.DBID 33P
ISSN 0014-5793
IngestDate Fri Aug 16 08:51:57 EDT 2024
Fri Nov 22 00:02:05 EST 2024
Sat Sep 28 08:37:00 EDT 2024
Sat Aug 24 00:48:51 EDT 2024
Fri Feb 23 02:33:16 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords TPP-I, tripeptidyl peptidase-I
Tripeptidyl peptidase-I
Lysosomal peptide degradation
MALDI-TOF-MS, matrix-assisted laser desorption ionisation-time of flight-mass spectrometry
Angiotensin-II
NHMec, -methylcoumarylamide
TFA, trifluoroacetic acid
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4264-fc862fb403051d35ad3926c2a5f009a3529e47fd46921b62465e5d283790e8f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1016/S0014-5793(01)02608-4
PMID 11445074
PQID 71000585
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_71000585
crossref_primary_10_1016_S0014_5793_01_02608_4
pubmed_primary_11445074
wiley_primary_10_1016_S0014_5793_01_02608_4_FEB2S0014579301026084
elsevier_sciencedirect_doi_10_1016_S0014_5793_01_02608_4
PublicationCentury 2000
PublicationDate July 06, 2001
PublicationDateYYYYMMDD 2001-07-06
PublicationDate_xml – month: 07
  year: 2001
  text: July 06, 2001
  day: 06
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle FEBS letters
PublicationTitleAlternate FEBS Lett
PublicationYear 2001
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Page, Fuller, Chambers, Warburton (BIB1) 1993; 307
Ezaki, Takeda-Ezaki, Oda, Kominami (BIB4) 2000; 268
Lin, Sohar, Lackland, Lobel (BIB7) 2001; 276
Mason, R.W. (1996) Biology of the Lysosome, in: Subcellular Biochemistry (Lloyd, J.B. and Mason, R.W., Eds.), Vol. 27, pp. 159–190, Plenum, New York.
Sleat, Donnelly, Lackland, Liu, Sohar, Pullarkat, Lobel (BIB6) 1997; 277
Palmer, Fearnley, Walker, Hall, Lake, Wolfe, Haltia, Martinus, Jolly (BIB13) 1992; 42
Bernardini, F. and Warburton, M.J. (2001) Eur. J. Pediatr. Neurol., in press.
Authier, Mort, Bell, Posner, Bergeron (BIB9) 1995; 270
Alves dos Santos, C.M., van Kerkhof, P. and Strous, G.J. (2001) J. Biol. Chem., in press.
Doebbler, Divor, Ellis (BIB19) 1978; 103
Vines, Warburton (BIB11) 1999; 443
Thomas, Thekkumkara, Baker (BIB17) 1996; 3
Junaid, Wu, Pullarkat (BIB3) 2000; 74
Vines, Warburton (BIB2) 1998; 1384
Balow, Tomkinson, Ragnarsson, Zetterqvist (BIB20) 1986; 261
Tomkinson, Wernstedt, Hellman, Zetterquist (BIB8) 1987; 84
Boustany, R.-M. (1996) Neurodystrophies and neurolipidoses, in: Handbook of Clinical Neurology (Moser, H.W., Ed.), Vol. 22, pp. 671–700, Elsevier Science, Amsterdam.
McDonald, Hoisington, Eisenbauer (BIB10) 1985; 126
Ezaki, Takeda-Ezaki, Kominami (BIB14) 2000; 128
Kargel, Dettmer, Etzold, Kirschke, Bohley, Titani (BIB21) 1981; 40
Rosche, F., Schmidt J., Hoffmann T., Pauly R.P., McIntosh C.H.S., Pederson R.A. and Demuth H.-U. (2000) in: Mass Spectrometry of Proteins and Peptides (Chapman, J.R., Ed.), pp. 251–272, Humana, Totowa, NJ.
2001; 276
1993; 307
1987; 84
2000; 268
2000; 128
2000; 74
1997; 277
1986; 261
1985; 126
1999; 443
1978; 103
1992; 42
1998; 1384
1996; 3
1981; 40
1995; 270
e_1_2_5_15_1
e_1_2_5_14_1
e_1_2_5_17_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_8_1
e_1_2_5_11_1
Kargel H.-J. (e_1_2_5_22_1) 1981; 40
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_21_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_20_1
References_xml – volume: 84
  start-page: 7508
  year: 1987
  end-page: 7512
  ident: BIB8
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Zetterquist
– volume: 126
  start-page: 63
  year: 1985
  end-page: 71
  ident: BIB10
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Eisenbauer
– volume: 276
  start-page: 2249
  year: 2001
  end-page: 2255
  ident: BIB7
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Lobel
– volume: 103
  start-page: 1794
  year: 1978
  end-page: 1804
  ident: BIB19
  publication-title: Endocrinology
  contributor:
    fullname: Ellis
– volume: 40
  start-page: 1139
  year: 1981
  end-page: 1143
  ident: BIB21
  publication-title: Acta Biol. Med. Ger.
  contributor:
    fullname: Titani
– volume: 277
  start-page: 1802
  year: 1997
  end-page: 1805
  ident: BIB6
  publication-title: Science
  contributor:
    fullname: Lobel
– volume: 268
  start-page: 904
  year: 2000
  end-page: 908
  ident: BIB4
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Kominami
– volume: 443
  start-page: 131
  year: 1999
  end-page: 135
  ident: BIB11
  publication-title: FEBS Lett.
  contributor:
    fullname: Warburton
– volume: 307
  start-page: 354
  year: 1993
  end-page: 359
  ident: BIB1
  publication-title: Arch. Biochem. Biophys.
  contributor:
    fullname: Warburton
– volume: 42
  start-page: 561
  year: 1992
  end-page: 567
  ident: BIB13
  publication-title: Am. J. Med. Genet.
  contributor:
    fullname: Jolly
– volume: 1384
  start-page: 233
  year: 1998
  end-page: 242
  ident: BIB2
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Warburton
– volume: 261
  start-page: 2409
  year: 1986
  end-page: 2417
  ident: BIB20
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Zetterqvist
– volume: 74
  start-page: 287
  year: 2000
  end-page: 294
  ident: BIB3
  publication-title: J. Neurochem.
  contributor:
    fullname: Pullarkat
– volume: 270
  start-page: 15798
  year: 1995
  end-page: 15807
  ident: BIB9
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Bergeron
– volume: 128
  start-page: 509
  year: 2000
  end-page: 516
  ident: BIB14
  publication-title: J. Biochem.
  contributor:
    fullname: Kominami
– volume: 3
  start-page: S74
  year: 1996
  end-page: 80
  ident: BIB17
  publication-title: Clin. Exp. Pharmacol. Physiol.
  contributor:
    fullname: Baker
– volume: 277
  start-page: 1802
  year: 1997
  end-page: 1805
  publication-title: Science
– volume: 307
  start-page: 354
  year: 1993
  end-page: 359
  publication-title: Arch. Biochem. Biophys.
– volume: 3
  start-page: S74
  year: 1996
  end-page: 80
  publication-title: Clin. Exp. Pharmacol. Physiol.
– volume: 40
  start-page: 1139
  year: 1981
  end-page: 1143
  publication-title: Acta Biol. Med. Ger.
– volume: 74
  start-page: 287
  year: 2000
  end-page: 294
  publication-title: J. Neurochem.
– volume: 443
  start-page: 131
  year: 1999
  end-page: 135
  publication-title: FEBS Lett.
– volume: 103
  start-page: 1794
  year: 1978
  end-page: 1804
  publication-title: Endocrinology
– volume: 84
  start-page: 7508
  year: 1987
  end-page: 7512
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 268
  start-page: 904
  year: 2000
  end-page: 908
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 261
  start-page: 2409
  year: 1986
  end-page: 2417
  publication-title: J. Biol. Chem.
– volume: 126
  start-page: 63
  year: 1985
  end-page: 71
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 128
  start-page: 509
  year: 2000
  end-page: 516
  publication-title: J. Biochem.
– volume: 270
  start-page: 15798
  year: 1995
  end-page: 15807
  publication-title: J. Biol. Chem.
– volume: 42
  start-page: 561
  year: 1992
  end-page: 567
  publication-title: Am. J. Med. Genet.
– volume: 276
  start-page: 2249
  year: 2001
  end-page: 2255
  publication-title: J. Biol. Chem.
– volume: 1384
  start-page: 233
  year: 1998
  end-page: 242
  publication-title: Biochim. Biophys. Acta
– ident: e_1_2_5_8_1
  doi: 10.1074/jbc.M008562200
– ident: e_1_2_5_12_1
  doi: 10.1016/S0014-5793(98)01683-4
– ident: e_1_2_5_9_1
  doi: 10.1073/pnas.84.21.7508
– ident: e_1_2_5_4_1
  doi: 10.1046/j.1471-4159.2000.0740287.x
– ident: e_1_2_5_16_1
– ident: e_1_2_5_5_1
  doi: 10.1006/bbrc.2000.2207
– ident: e_1_2_5_13_1
– ident: e_1_2_5_14_1
  doi: 10.1002/ajmg.1320420428
– ident: e_1_2_5_20_1
  doi: 10.1210/endo-103-5-1794
– ident: e_1_2_5_15_1
  doi: 10.1093/oxfordjournals.jbchem.a022781
– ident: e_1_2_5_2_1
  doi: 10.1006/abbi.1993.1523
– ident: e_1_2_5_10_1
  doi: 10.1074/jbc.270.26.15798
– ident: e_1_2_5_6_1
– ident: e_1_2_5_18_1
  doi: 10.1111/j.1440-1681.1996.tb02817.x
– ident: e_1_2_5_11_1
  doi: 10.1016/0006-291X(85)90571-6
– ident: e_1_2_5_3_1
  doi: 10.1016/S0167-4838(98)00012-0
– ident: e_1_2_5_17_1
  doi: 10.1007/978-1-4615-5833-0_6
– ident: e_1_2_5_7_1
  doi: 10.1126/science.277.5333.1802
– ident: e_1_2_5_19_1
– volume: 40
  start-page: 1139
  year: 1981
  ident: e_1_2_5_22_1
  publication-title: Acta Biol. Med. Ger.
  contributor:
    fullname: Kargel H.-J.
– ident: e_1_2_5_21_1
  doi: 10.1016/S0021-9258(17)35951-3
SSID ssj0001819
Score 1.7780572
Snippet Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but...
Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but...
SourceID proquest
crossref
pubmed
wiley
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 145
SubjectTerms Amino Acid Substitution
Aminopeptidases
Angiotensin II - analogs & derivatives
Angiotensin II - chemistry
Angiotensin II - drug effects
Angiotensin-II
Animals
Catalysis
Chromatography, High Pressure Liquid
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Endopeptidases - chemistry
Endopeptidases - pharmacology
Hydrogen-Ion Concentration
Lysosomal peptide degradation
Lysosomes - enzymology
MALDI-TOF-MS, matrix-assisted laser desorption ionisation-time of flight-mass spectrometry
Neuronal Ceroid-Lipofuscinoses - enzymology
NHMec, -methylcoumarylamide
Peptides - chemistry
Peptides - drug effects
Serine Proteases
Structure-Activity Relationship
Substrate Specificity - physiology
Swine
TFA, trifluoroacetic acid
TPP-I, tripeptidyl peptidase-I
Tripeptidyl peptidase-I
Title The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues
URI https://dx.doi.org/10.1016/S0014-5793(01)02608-4
https://onlinelibrary.wiley.com/doi/abs/10.1016%2FS0014-5793%2801%2902608-4
https://www.ncbi.nlm.nih.gov/pubmed/11445074
https://search.proquest.com/docview/71000585
Volume 500
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSyQxEA6uIO7F566OzxxE9NBrv9KTPo46w4iwLKjgLaQ7iQw43WLPHObmT_A3-kusSrpnFJH1IPQh5EU6qSRfJVVfCDlIuOEyV6mnNF4zhkHu8TxNvUwpLlkURlGG3sj9q_bfW37eRZqcy8YXxvFDTA_ccGbY9RonuMyqN_rmFaJ7j7WRDYkj3XyK9FjcQ25Q0BqsO0f0b7oqw07moHBdaObNczKr6cgPjutaPtunPuLQ97DW7ku95W_9oxWyVMNT2nHytErmdLFG1jsFqObDCT2k1mDUnsSvkYXTJrR41jwbt06GIHgU_TfRBgkgPi0NvZ9UZVUOoeIRrFFoR6Mm99QFYBd9eXq-oKq2y9GKZhM6GFXUuVxQ-GRxNyitqX2BeS8gwp05Vb_ITa97fdb36jcdvByxl2dyUKFMFuM6E6iISQUALclDyQygPQlwMNVx2yjQ2sMgS8I4YZoppOhJfc0Ni36T-aIs9CahqQwSwwwgPsiuJJNJO8hAtGLDIxlxv0X-NCMoHhx1h5jZtEFXC-xq4QfCdrOIW4Q34yxq_OFwhYCx-l_R_UYuBPQ3XrrIQpfjSiB7kg86WYtsOHGZtQV0WUDjULZjpeJrjRS97mloUzABGQEhOt76hjq2yU9nYIf2kDtkfvQ41rvkR6XGe3YqvQLrjRY7
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB71IVQutLQUFvrwASE4BPJy1jluy652xVIhtUjcLCe2q0rdBJHdw974CfzG_pLO2EkXhBA9VMrB8kuOPba_sWc-A7zOhBWq1HmgDV0zxlEZiDLPg0JroXgSJ0lB3sjj8_7ZN_FxSDQ5084XxvND3B240cxw6zVNcDqQ_k3hPCd4H_A-0SEJ4pvPiR9LBOk6bKYZCiY5dCRf7tZl3Ms8GG5Lrfx5PqyqehtG79pq_rVT_Y1E_wS2bmcabT_sP-3AkxahsoEXqaewZqpd2BtUqJ3PluwNczaj7jB-Fx6ddKGt0-7luD2YoewxcuEkMyRE-ay27HrZ1E09w4rnuEyRKY1eXjMfwI305uevCdOtaY7RrFiyq3nDvNcFw09Vl1e1s7avKO8EI_yxU_MMvo6GF6fjoH3WISgJfgW2RC3KFiktNZFOuNKI0bIyVtwi4FOICHOT9q1GxT2OiixOM264JpaePDTC8mQfNqq6Mi-A5SrKLLcI-jC7Vlxl_ahA6UqtSFQiwh6874ZQfvfsHXJl1oZdLamrZRhJ180y7YHoBlq2EMRDC4mD9b-ix51gSOxvundRlakXjSQCpRDVsh489_KyaguqswjIsezAicX9GilHw5PYpVACkQJidPryAeo4hq3xxeepnE7OPr2Cx97ejswjD2Bj_mNhDmG90YsjN69uAZs0GmM
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4VqhYufUAf2xc-VFV7CE3iOOscF9gVKyqERCv1ZjmxXSGxCSK7h73xE_iN_JLO2AnbqqraA1IOll9y7LH9jT3zGeB9Lp3UlSkiY-maMU2qSFZFEZXGSC14ynlJ3siHp8Pj7_JgTDQ5R70vTOCHuD1wo5nh12ua4BfG_aJvnhK6j8SQ2JAk0c0XRI8lo2wN7mcIy4lIn_OT22UZt7KAhbtSK3eez6uqPsbJp66av21UfwLR33Gt35gmj-_0l57Aow6fslEQqKdwz9ZbsD2qUTefLdkH5i1G_VH8FjzY60Mb-_27cdswQ8lj5MBJRkiI8Vnj2PmybdpmhhXPcZEiQxqzPGchgNvozdX1lJnOMMcaVi7Z2bxlweeC4afrH2eNt7WvKe8UI8KhU_sMvk3GX_cPo-5Rh6gi8BW5CnUoV2a00CSGC20QoeVVqoVDuKcRDxY2GzqDanualHma5cIKQxw9RWylE_w5rNdNbV8CK3SSO-EQ8mF2o4XOh0mJspU5yTWX8QB2-xFUF4G7Q62M2rCrFXW1ihPlu1llA5D9OKsOgARgoXCs_lV0p5cLhf1Nty66ts2iVUSfFKNSNoAXQVxWbUFlFuE4lh15qfi_RqrJeC_1KZRAlIAYnb26gzp24OHJwUR9mR4fvYbNYGxHtpFvYH1-ubBvYa01i3d-Vv0E88MZCQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+specificity+of+lysosomal+tripeptidyl+peptidase-I+determined+by+its+action+on+angiotensin-II+analogues&rft.jtitle=FEBS+letters&rft.au=Warburton%2C+Michael+J&rft.au=Bernardini%2C+Francesca&rft.date=2001-07-06&rft.pub=Elsevier+B.V&rft.issn=0014-5793&rft.eissn=1873-3468&rft.volume=500&rft.issue=3&rft.spage=145&rft.epage=148&rft_id=info:doi/10.1016%2FS0014-5793%2801%2902608-4&rft.externalDocID=S0014579301026084
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-5793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-5793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-5793&client=summon